APO Research
Talk to an analyst

APO RESEARCH · REPORT

Progressive Multifocal Leukoencephalopathy Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Progressive Multifocal Leukoencephalopathy Drug Industry Growth and Trends Forecast to 2032

19 December 202593 pages

Choose your research edition.

Industry ResearchProgressive Multifocal Leukoencephalopathy Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Progressive Multifocal Leukoencephalopathy Drug Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Progressive Multifocal Leukoencephalopathy Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Progressive Multifocal Leukoencephalopathy Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Progressive Multifocal Leukoencephalopathy Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Progressive Multifocal Leukoencephalopathy Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Progressive Multifocal Leukoencephalopathy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Progressive Multifocal Leukoencephalopathy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Progressive Multifocal Leukoencephalopathy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Progressive Multifocal Leukoencephalopathy Drug include Pomona Ricerca SRL, Neuway Pharma GmbH, Neurimmune Holding AG, Humabs BioMed SA and Excision BioTherapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Progressive Multifocal Leukoencephalopathy Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Progressive Multifocal Leukoencephalopathy Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Progressive Multifocal Leukoencephalopathy Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Progressive Multifocal Leukoencephalopathy Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Progressive Multifocal Leukoencephalopathy Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Progressive Multifocal Leukoencephalopathy Drug Market by Company

Pomona Ricerca SRL

Neuway Pharma GmbH

Neurimmune Holding AG

Humabs BioMed SA

Excision BioTherapeutics Inc

Progressive Multifocal Leukoencephalopathy Drug Segment by Type

Imatinib Mesylate

NI-307

IKT-01427

EBT-103

Others

Progressive Multifocal Leukoencephalopathy Drug Segment by Application

Clinic

Hospital

Research Center

Progressive Multifocal Leukoencephalopathy Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Progressive Multifocal Leukoencephalopathy Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Progressive Multifocal Leukoencephalopathy Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Progressive Multifocal Leukoencephalopathy Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Progressive Multifocal Leukoencephalopathy Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Progressive Multifocal Leukoencephalopathy Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Imatinib Mesylate Table 2. Major Company of NI-307 Table 3. Major Company of IKT-01427 Table 4. Major Company of EBT-103 Table 5. Major Company of Others Table 6. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (K Units) Table 8. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Progressive Multifocal Leukoencephalopathy Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2027-2032) & (K Units) Table 13. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Progressive Multifocal Leukoencephalopathy Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (K Units) Table 18. North America Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Progressive Multifocal Leukoencephalopathy Drug Industry Trends Table 28. Progressive Multifocal Leukoencephalopathy Drug Industry Drivers Table 29. Progressive Multifocal Leukoencephalopathy Drug Industry Opportunities and Challenges Table 30. Progressive Multifocal Leukoencephalopathy Drug Industry Restraints Table 31. Global Progressive Multifocal Leukoencephalopathy Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Company (2021-2026) Table 33. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Company (2021-2026) & (K Units) Table 34. Global Progressive Multifocal Leukoencephalopathy Drug Sales Share by Company (2021-2026) Table 35. Global Progressive Multifocal Leukoencephalopathy Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Progressive Multifocal Leukoencephalopathy Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Progressive Multifocal Leukoencephalopathy Drug Major Company Production Sites and Headquarters Table 38. Global Progressive Multifocal Leukoencephalopathy Drug Company, Product Type & Application Table 39. Global Progressive Multifocal Leukoencephalopathy Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Progressive Multifocal Leukoencephalopathy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Progressive Multifocal Leukoencephalopathy Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Progressive Multifocal Leukoencephalopathy Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Progressive Multifocal Leukoencephalopathy Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Progressive Multifocal Leukoencephalopathy Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2027-2032) & (K Units) Table 60. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Progressive Multifocal Leukoencephalopathy Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (K Units) Table 65. North America Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Pomona Ricerca SRL Company Information Table 75. Pomona Ricerca SRL Business Overview Table 76. Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Product Portfolio Table 78. Pomona Ricerca SRL Recent Development Table 79. Neuway Pharma GmbH Company Information Table 80. Neuway Pharma GmbH Business Overview Table 81. Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Product Portfolio Table 83. Neuway Pharma GmbH Recent Development Table 84. Neurimmune Holding AG Company Information Table 85. Neurimmune Holding AG Business Overview Table 86. Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Product Portfolio Table 88. Neurimmune Holding AG Recent Development Table 89. Humabs BioMed SA Company Information Table 90. Humabs BioMed SA Business Overview Table 91. Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Product Portfolio Table 93. Humabs BioMed SA Recent Development Table 94. Excision BioTherapeutics Inc Company Information Table 95. Excision BioTherapeutics Inc Business Overview Table 96. Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Product Portfolio Table 98. Excision BioTherapeutics Inc Recent Development Table 99. North America Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 100. North America Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2021-2026) & (K Units) Table 101. North America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country (2021-2026) Table 102. North America Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2027-2032) & (K Units) Table 103. North America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share Forecast by Country (2027-2032) Table 104. North America Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Progressive Multifocal Leukoencephalopathy Drug Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Progressive Multifocal Leukoencephalopathy Drug Market Share by Country (2021-2026) Table 107. North America Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Progressive Multifocal Leukoencephalopathy Drug Market Share Forecast by Country (2027-2032) Table 109. Europe Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2021-2026) & (K Units) Table 111. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country (2021-2026) Table 112. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2027-2032) & (K Units) Table 113. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Progressive Multifocal Leukoencephalopathy Drug Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Progressive Multifocal Leukoencephalopathy Drug Market Share by Country (2021-2026) Table 117. Europe Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Progressive Multifocal Leukoencephalopathy Drug Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2021-2026) & (K Units) Table 121. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2027-2032) & (K Units) Table 123. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Share by Country (2021-2026) Table 127. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Share Forecast by Country (2027-2032) Table 129. Latin America Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2021-2026) & (K Units) Table 131. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country (2021-2026) Table 132. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2027-2032) & (K Units) Table 133. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Progressive Multifocal Leukoencephalopathy Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Progressive Multifocal Leukoencephalopathy Drug Market Share by Country (2021-2026) Table 137. Latin America Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Progressive Multifocal Leukoencephalopathy Drug Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2021-2026) & (K Units) Table 141. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2027-2032) & (K Units) Table 143. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Share by Country (2021-2026) Table 147. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Progressive Multifocal Leukoencephalopathy Drug Distributors List Table 152. Progressive Multifocal Leukoencephalopathy Drug Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Progressive Multifocal Leukoencephalopathy Drug Image Figure 2. Global Progressive Multifocal Leukoencephalopathy Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Progressive Multifocal Leukoencephalopathy Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Progressive Multifocal Leukoencephalopathy Drug Sales (2021-2032) & (K Units) Figure 5. Imatinib Mesylate Image Figure 6. Global Imatinib Mesylate Sales YoY Growth (2021-2032) & (K Units) Figure 7. NI-307 Image Figure 8. Global NI-307 Sales YoY Growth (2021-2032) & (K Units) Figure 9. IKT-01427 Image Figure 10. Global IKT-01427 Sales YoY Growth (2021-2032) & (K Units) Figure 11. EBT-103 Image Figure 12. Global EBT-103 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Progressive Multifocal Leukoencephalopathy Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Progressive Multifocal Leukoencephalopathy Drug Market Share by Type 2025 VS 2032 Figure 17. North America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Progressive Multifocal Leukoencephalopathy Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Research Center Image Figure 34. Global Research Center Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Progressive Multifocal Leukoencephalopathy Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Progressive Multifocal Leukoencephalopathy Drug Market Share by Application 2025 VS 2032 Figure 37. North America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Progressive Multifocal Leukoencephalopathy Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Progressive Multifocal Leukoencephalopathy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Progressive Multifocal Leukoencephalopathy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Progressive Multifocal Leukoencephalopathy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Progressive Multifocal Leukoencephalopathy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Progressive Multifocal Leukoencephalopathy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Progressive Multifocal Leukoencephalopathy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Progressive Multifocal Leukoencephalopathy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Progressive Multifocal Leukoencephalopathy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Progressive Multifocal Leukoencephalopathy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Progressive Multifocal Leukoencephalopathy Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Progressive Multifocal Leukoencephalopathy Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Imatinib Mesylate
  • NI-307
  • IKT-01427
  • EBT-103
  • Others
Applications
  • Clinic
  • Hospital
  • Research Center
Companies covered
  • Pomona Ricerca SRL
  • Neuway Pharma GmbH
  • Neurimmune Holding AG
  • Humabs BioMed SA
  • Excision BioTherapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Progressive Multifocal Leukoencephalopathy Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Progressive Multifocal Leukoencephalopathy Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Progressive Multifocal Leukoencephalopathy Drug Market by Type
  6. 1.3.1 Imatinib Mesylate
  7. 1.3.2 NI-307
  8. 1.3.3 IKT-01427
  9. 1.3.4 EBT-103
  10. 1.3.5 Others
  11. 1.4 Global Progressive Multifocal Leukoencephalopathy Drug Market Size by Type
  12. 1.4.1 Global Progressive Multifocal Leukoencephalopathy Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Progressive Multifocal Leukoencephalopathy Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Progressive Multifocal Leukoencephalopathy Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Progressive Multifocal Leukoencephalopathy Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Progressive Multifocal Leukoencephalopathy Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Progressive Multifocal Leukoencephalopathy Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Progressive Multifocal Leukoencephalopathy Drug Industry Trends
  2. 2.2 Progressive Multifocal Leukoencephalopathy Drug Industry Drivers
  3. 2.3 Progressive Multifocal Leukoencephalopathy Drug Industry Opportunities and Challenges
  4. 2.4 Progressive Multifocal Leukoencephalopathy Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Progressive Multifocal Leukoencephalopathy Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Progressive Multifocal Leukoencephalopathy Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Progressive Multifocal Leukoencephalopathy Drug Price (2021-2026)
  4. 3.4 Global Progressive Multifocal Leukoencephalopathy Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Progressive Multifocal Leukoencephalopathy Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Progressive Multifocal Leukoencephalopathy Drug Company, Product Type & Application
  7. 3.7 Global Progressive Multifocal Leukoencephalopathy Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Progressive Multifocal Leukoencephalopathy Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Progressive Multifocal Leukoencephalopathy Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Progressive Multifocal Leukoencephalopathy Drug Tier 1, Tier 2, and Tier 3
4 Progressive Multifocal Leukoencephalopathy Drug Regional Status and Outlook
  1. 4.1 Global Progressive Multifocal Leukoencephalopathy Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Progressive Multifocal Leukoencephalopathy Drug Historic Market Size by Region
  3. 4.2.1 Global Progressive Multifocal Leukoencephalopathy Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Progressive Multifocal Leukoencephalopathy Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Progressive Multifocal Leukoencephalopathy Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Progressive Multifocal Leukoencephalopathy Drug Forecasted Market Size by Region
  7. 4.3.1 Global Progressive Multifocal Leukoencephalopathy Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Progressive Multifocal Leukoencephalopathy Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Progressive Multifocal Leukoencephalopathy Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Progressive Multifocal Leukoencephalopathy Drug by Application
  1. 5.1 Progressive Multifocal Leukoencephalopathy Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Research Center
  5. 5.2 Global Progressive Multifocal Leukoencephalopathy Drug Market Size by Application
  6. 5.2.1 Global Progressive Multifocal Leukoencephalopathy Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Progressive Multifocal Leukoencephalopathy Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Progressive Multifocal Leukoencephalopathy Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Progressive Multifocal Leukoencephalopathy Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Progressive Multifocal Leukoencephalopathy Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Progressive Multifocal Leukoencephalopathy Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pomona Ricerca SRL
  2. 6.1.1 Pomona Ricerca SRL Company Information
  3. 6.1.2 Pomona Ricerca SRL Business Overview
  4. 6.1.3 Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Product Portfolio
  6. 6.1.5 Pomona Ricerca SRL Recent Developments
  7. 6.2 Neuway Pharma GmbH
  8. 6.2.1 Neuway Pharma GmbH Company Information
  9. 6.2.2 Neuway Pharma GmbH Business Overview
  10. 6.2.3 Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Product Portfolio
  12. 6.2.5 Neuway Pharma GmbH Recent Developments
  13. 6.3 Neurimmune Holding AG
  14. 6.3.1 Neurimmune Holding AG Company Information
  15. 6.3.2 Neurimmune Holding AG Business Overview
  16. 6.3.3 Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Product Portfolio
  18. 6.3.5 Neurimmune Holding AG Recent Developments
  19. 6.4 Humabs BioMed SA
  20. 6.4.1 Humabs BioMed SA Company Information
  21. 6.4.2 Humabs BioMed SA Business Overview
  22. 6.4.3 Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Product Portfolio
  24. 6.4.5 Humabs BioMed SA Recent Developments
  25. 6.5 Excision BioTherapeutics Inc
  26. 6.5.1 Excision BioTherapeutics Inc Company Information
  27. 6.5.2 Excision BioTherapeutics Inc Business Overview
  28. 6.5.3 Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Product Portfolio
  30. 6.5.5 Excision BioTherapeutics Inc Recent Developments
7 North America by Country
  1. 7.1 North America Progressive Multifocal Leukoencephalopathy Drug Sales by Country
  2. 7.1.1 North America Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Progressive Multifocal Leukoencephalopathy Drug Market Size by Country
  6. 7.2.1 North America Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Progressive Multifocal Leukoencephalopathy Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Country
  2. 8.1.1 Europe Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Progressive Multifocal Leukoencephalopathy Drug Market Size by Country
  6. 8.2.1 Europe Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Progressive Multifocal Leukoencephalopathy Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Country
  2. 9.1.1 Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Progressive Multifocal Leukoencephalopathy Drug Sales by Country
  2. 10.1.1 South America Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Progressive Multifocal Leukoencephalopathy Drug Market Size by Country
  6. 10.2.1 South America Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Progressive Multifocal Leukoencephalopathy Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Country
  2. 11.1.1 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Progressive Multifocal Leukoencephalopathy Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Progressive Multifocal Leukoencephalopathy Drug Value Chain Analysis
  2. 12.1.1 Progressive Multifocal Leukoencephalopathy Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Progressive Multifocal Leukoencephalopathy Drug Production Mode & Process
  7. 12.2 Progressive Multifocal Leukoencephalopathy Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Progressive Multifocal Leukoencephalopathy Drug Distributors
  10. 12.2.3 Progressive Multifocal Leukoencephalopathy Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst